Characterization of lower respiratory tract inflammation in patients with smear negative pulmonary tuberculosis by Vijayan, V K et al.
CHARACTERISATION OF LOWER RESPIRATORY-TRACT
INFLAMMATION IN PATIENTS WITH SMEAR-NEGATIVE
PULMONARY TUBERCULOSIS
VIJAYAN, VK., SANKARAN, K., VENKATESAN, P. AND PRABHAKAR, R.
Cardio - Pulmonary Medicine Unit, Tuberculosis Research Centre, Indian Council of Medical
Research, Madras 600 031.
(Received original January 1994; revised May 1994)
ABSTRACT
Bronchoalveolar lavage (BAL) studies were carried out in 27 sputums ear negative but
radiographic probable pulmonary tuberculosis patients to characterize the inflammatory and Immune
effector cells in the lower respiratory tract and in 17 normal subjects. The diagnosis of active pulmonary
tuberculosis was confirmed by isolation of Mycobacterium tuberculosis in culture from sputum and/or
lavage specimens. BAL was done first from radiologically normal lobe and then from radiologically
abnormal lobe prior to treatment and the BAL fluids were analyzed separately. Two groups were identified
based on lavage results. One group (macrophage predominant) had significantly elevated total cells and
alveolar macrophages in both radiologically normal (p<0.01) and abnormal lobes (p<0.001) compared to
normal controls. The other group (lymphocyte predominant) had expanded numbers of total cells
(p<0.01), lymphocytes (p<0.01), neutrophlls (p<0.05) and eosinophils (p<0.01) in radiologically abnormal
lobe. The cell profile in radiologically normal lobe in lymphocyte predominant group was within normal
limits. These results suggest that two distinct cell profiles, in o e group an increase in alveolar
macrophages and in the other an increase in lymphocytes can occur In the lower respiratory tract of
patients with sputum smear negative, but radiographic probable pulmonary tuberculosis.
Introduction
Although treatment for pulmonary tuberculosis
p&vents the replication of mycobacteria and
re duces the mycobacterial load thereby reducing the
immune- mediated lung injury, the lung damage in
tuberculosis results from host reaction rather than by
direct bacterial effects (1). In conformity with this, it
had been noticed that radiographic and pulmonary
function abnormalities persist in a proportion of
patients despite treatment with potent regimens (2-
4). Thus in order to “treat” all pulmonary tuberculosis
patients successfully, we should be able to prevent
the lung damage and subsequent fibrosis. However,
the pathogenesis and mechanism of lung injury and
fibrosis in pulmonary tuberculosis are not well
understood to formulate modalities of treatment that
may prevent fibrosis. Bronchoalveolar lavage (BAL)
Studies have been found to be useful in better
understanding of pathogenesis and development of
fibrosis in various interstitial lung diseases (5). There
are also reports of cellular compositions of BAL fluid
in pulmonary tuberculosis (6-10). Bronchoalveolar
lavage studies of tuberculosis patients may,
therefore, help to assess the role of inflammatory
and immune effector cells in lower respiratory tract
(LRT) in mediating injury and fibrosis. A preliminary
study was, therefore, planned to characterise the
inflammatory and immune effector cells in the lower
respiratory tract of sputum smear negative, but
radiographic probable pulmonary tuberculosis
patients using BAL.
Materials and Methods
Study subjects
Sixty nine patients presenting with respiratory
symptoms such as cough, fever, haemoptysis and
loss of weight for less than four months, and at least
four sputum smears negative for acid fast bacilli
(AFB), but with radiographic appearances
suggestive of pulmonary tuberculosis were
evaluated by BAL during a four-year period. The
duration of disease was calculated from the onset of
symptoms as provided by the patient during initial
interrogation by the chest physician (VKV). The
diagnosis of tuberculosis was based on the
demonstration of M. tuberculosis in culture in sputum
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or BAL fluid. None had received any anti
tuberculosis treatment in the past. Skin tests were
done by the intradermal Mantoux technique with one
tuberculin unit purified protein derivative (PPD RT 23
with Tween 80) and were examined at 48 or 72
hours. Full-size postero-anterior chest radiographs
were assessed by the International Labour
Organisation (ILO) criteria (11). None of them was
suffering from diabetes mellitus as assessed by
urine examination for sugar or receiving
immunosuppressive drugs.
and all had normal chest radiographs and normal
pulmonary function tests. None of the subjects were
on any medication.
Classification of BAL results.
Occupational history revealed shop workers
(eight) plumber and turner (two), executive, rickshaw
puller, labourer, milkman, driver, tinkering and
gardening work (one each). Three were unemployed
and seven were housewives. None had been
exposed regularly to dusts / chemical: at
occupation. Four patients gave a family / contact
history of tuberculosis. Informed consent was
obtained from each subject and the study was
approved by the Institutional Ethical Committee.
If lymphocytes in BAL fluid are more than 22%
(more than one SD above normal mean) and
macrophages less than 75% (less than one SD
below normal mean) from radiologically abnormal
lobe, it was classified as lymphocyte predominant. If
lymphocytes are less than 22% and macrophages
more than 75%, it was classified as macrophage
predominant. We had not done subtyping of
lymphocytes.
Statistical analysis
The results are presented as mean ± SEM. All
the mean differences between groups were
compared using Mann-Whitney U test.
Results
Bronchoalveolar lavage.
Bronchoalveolar lavages were performed with
a flexible fibreoptic bronchoscope as previously
described (12). The lavages were done from two
sites, first from a radiologically abnormal lobe in
patients with localised disease. The normal site
selected for lavage was always from the
contralateral normal lung and was usually middle
lobe or lingula. Five 20 ml aliquots of normal saline
solution at room temperature were instilled into each
lobe and recovered immediately with the
bronchoscope wedged in a subsegmental bronchus.
The fluid from each lobe was analysed separately.
Filter preparations were made for differential cell
counts on lavage fluid (uncentrifuged cells) as
reported by Saltini et al(13) and were stained with
haematoxylin-eosin. A minimum of 400 cells was
counted for differential cell counts on each filter
preparation by two observers (VKV, KS) and
recorded independently. Both observers agreed to
within 5% of all lavage analysis and the mean value
was used for analysis. The absolute numbers of
different types of cells were derived from total cells
times differential percentages.
Of the 69 patients assessed, 27 had
bacteriological confirmation by sputum culture
including 18 in whom BAL fluid cultures were also
positive for M. tuberculosis. The mean age of these
27 subjects was 29.1 ± 1.63 Yrs (range 17 to 45
years) and the mean weight was 44.4 ± 1.03 Kg.
(range 36.6 to 55.7 Kg.). There were 20 males and
seven females Eleven subjects were smokers. Four
had smoked more than 10 beedis/cigarettes daily for
more than five years. The mean duration of
symptoms was 1.7±0.24 months (range seven days
to four months). and the mean reaction to PPD was
19.9±1.3 mm (range 10 to 40 mm.). All had
radiographic abnormalities of category A (11) with
exudative pattern confined to one of the upper zones
and none had cavitary lesions. Based on the BAL
results, two groups were identified. There were
fourteen patients with predominance of
macrophages (Group I) and 13 with predominance
of lymphocytes (Group 2).
Normal subjects.
Seventeen non-smoking individuals (13 males,
four females) were evaluated as control subjects.
The mean age of normal subjects was 25.8 ± 2.1
years (range 17-53 years). None of them had
respiratory symptoms or abnormal physical findings
Group 1 (Macrophage Predominant)
There were nine males and five females in this
group. The mean age was 29.1±2.2 Yrs (range 22 -
45 years) and six were smokers. There were no
difference in lavage findings between smokers and
non-smokers. The mean duration of symptoms was
1.5 ± 0.26 months (range seven days to three
months) and the mean body weight was 43.9±1.4kg
(range 36.6 to52.0). The mean reaction to PPD in
this group was 19.5±1.9 mm. (range 10 to 40 mm.).
BAL results are shown in the Table.
Vijayan et al: BAL in smear negative Tuberculosis
TABLE
65
Inflammatory and Immune effector cells in the lower respiratory tract
(Mean ± SEM)
Normal Macrophage Predominant Lymphocyte Predominant
Subjects
  (n:17) RNS RAS RNS RAS
(n:14) (n:14) (n:13) (n:13)
Total cells, (x 106/dl)
33.6±7.0**
Macrophages %
x 106/dl
Lymphocytes, %
" x 106/dl
Neutrophils. %
" x 106/dl
Eosinophils, %
" x 106/dl
% Recovery
16.1±1.6 25.9±3.8** 32.6±3.3*** 29.0±7.3
 83.5±1.5  89.1±2.2*      90.2±1.4**    77.1±4.9   56.1±5.2*** ££
13.4±1.4  23.8±3.8** 29.5±3.1*** 23.8±7.1 17.1±3.7
14.9±1.6 8.9±1.9* 7.3±1.1** 20.6±4.9 40.0±5.3*** ££
2.5±0.4 1.7±0.3 2.2±0.3 4.8±1.5 15.1±4.7** £
0.7±0.2 1.0±0.3 1.1±0.5 0.9±0.2 1.7±0.4**
0.1±0.03 0.2±0.05 0.4±0.2 0.3±0.1 0.8±0.3*
0.9±0.3 1.0±0.3 1.4±0.4 1.4±0.4 2.2±0.6**
0.1±0.03 0 .2±0.05   0.5±0.2 0.3±0.1 0.7±0.2**
59.6±1.6 62.6±4.1 63.4±4.2 64.6±0.8 59.3±1.3
RNS : Radiologically normal site
RAS : Radiologically abnormal site
p values * < 0.05, ** <0.01,*** <0.001 as compared to normal subjects
£ <0.05, ££ <0.01, as compared radiologically normal site.
Total inflammatory ceils and absolute (total)
numbers of alveolar macrophages were significantly
higher in both radiologically abnormal (p < 0.001)
and normal (p < 0.01) lobes compared to normal
su bjects. Other types of cells were similar in both
abnormal and normal lobes on comparison with
normals. This was true whether all,, individuals or
only non-smokers were considered. Because of a
significant rise in macrophage percentages at both
sites. there was a reciprocal significant reduction in
lymphocyte percentages.However, total
lymphocytes were normal at both sites. The fluid
recovery was similar in normal subjects and patients
in both lobes.
Group 2 (Lymphocyte Predominant)
Of the 13 patients in this. group, two were
females and five were smokers. BAL results
between smokers and non-smokers were similar.
The mean age was 29.0 ± 2.5 Yrs (range 17- 44
years). The mean duration of symptoms was 2.1 ±
0.5 months (range 15 days to four months) and the
mean body weight was 45.1±1.5 kg (38.5 to 55.7).
  The mean reaction to PPD in these patients was
20.6±1.6 mm. (range 14 to 28 mm.). BAL results in
Group 2 patients are given in Table. The total
inflammatory ceils (p<0.01), lymphocytes (p<0.01),
neutrophils (p<0.05) and eosinophils (p<0.01) were
significantly higher in radiologically abnormal site
compared to normal subjects. This was true whether
all individuals or only non-smokers were
considered. There was also a significant increase in
the proportion of lymphocytes, neutrophils and
eosnophils and a significant reduction in proportion
of alveolar macrophages at radiologically abnormal
site. Total lymphocytes (p<0.05) and eosinophils
(p<0.05) were also significantly higher at
radiologically abnormal site in comparison with
radiologically normal site. All types of cells were
similar except for a suggestion of an increase in total
inflammatory cells (p = 0.06) in radiologically normal
site in comparison with normal subjects. Fluid
recovery was similar in normal subjects and patients
in this group.
Discussion
We have demonstrated in this study that two
distinct cell profiles, one group with an increase in
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alveolar macrophages and the other with an
increase in lymphocytes can occur in the tower
respiratory tract of patients with sputum smear-
negative but radiographic probable, pulmonary
tuberculosis . We had earlier reported that a third
type of cell profile with an increase in granulocytes
(neutrophils and eosinophils) can also occur in
smear negative pulmonary tuberculosis (14). Since
the age, smoking habit, fluid recovery during BAL,
the reaction to PPD, the nutritional status as
assessed by body weight and the radiological
abnormalities were similar in both groups. the
reason for the observed difference in cell profile
between the two groups could not be explained,
except for a suggestion that the duration of illness
(1.5±0.26 vs 2.1±0.5 months; is longer in
lymphocyte predominant group. Neutrophils are the
first cells to appear in tuberculosis exudate (15) and
the BAL findings of granulocyte accumulation in
tuberculosis patients (14) may thus represent the
earliest response after inhalation of Mycobacterium
tuberculosis into an alveolus. The demonstration of
abnormally elevated macrophages in the
radiologically normal and abnormal lobes of
pulmonary tuberculosis patients in this study may
represent recruitment of monocytes to the lungs( 16)
from the circulating pool of peripheral blood
monocytes (17) by the chemotactins released by
neutrophils( 18). Expanded numbers of alveolar
macrophages alone in lower respiratory tract had
been described in early stages of pneumoconioses
(19,20) and subacute phase of toxic gas exposure
(12). Macrophage activation is characterised by
spontaneous release of reactive oxygen species and
a number of a microbicidal enzymes by these cells
(21-23). We had reported previously that alveolar
macrophages from tuberculous patients were
activated as evidenced by spontaneous release of
hydrogen peroxide (H2O2) by these cells (24).
Lymphocytes which are building blocks of
granuloma are recruited to the site of lesion and
activated by interleukin-I and gamma-interferon
released by activated macrophages (25). Thus
lymphocytosis at radiologically abnormal but not in
radiologically normal lobe in this study may
represent the localisation of granuloma at the site of
lesion. Other cell types such as neutrophils and
eosinophils also contribute to granuloma formation
(16) and in conformity with this, there is a significant
elevation of neutrophils and eosinophils in
radiologically abnormal lobe in this study as well.
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Previous workers had demonstrated BAL
lymphocytosis in sputum smear positive pulmonary
tuberculous patient (6-8). It had also been observed
that lymphocytosis occurred in active tuberculous
lesion, but not in non-affected parts of the lungs (8),
as seen in this study. In a study of sputum smear
negative pulmonary tuberculosis, lymphocytosis was,
observed in 55% of patients at local site (9) and this
was similar to the observation of lymphocytosis in
48% (13 of 27) of patients in our series. Generalised
lymphocytosis in lung has been described in other
granulomatous lung diseases such as sarcoidosis,
hypersensitivity pneumonitis and berylilosis (5). The
main type of lymphocytes in tuberculous granuloma
is T cells (6,26) and an increase in CD4+  T cells is
also demonstrated in tuberculous pleural effusion
(27). Activated T cells are capable of spontaneously
releasing lymphokines such as interleukin-2, gamma
interferon and tumor necrosis factor and play an
important role in immune response in tuberculosis
(16,25). The demonstration of expanded numbers of
alveolar macrophages in both radiologically normal
and abnormal lobes of patients with shorter duration
of symptoms may suggest the possibility that
monocyte/macrophage recruitment to the lung
precedes lymphocyte recruitment and granuloma
formation at the site of lesion following tuberculous
infection. This may further be suggested by the fact
that abnormal accumulation of lymphocytes and
granulocytes were seen only in radiographically
abnormal lung segments of patients with longer
duration of symptoms. However, there was no
significant difference in duration of symptoms
between the two groups for a definite conclusion.
A dissociation of cell mediated immunity (CMI)
and delayed type hypersensitivity(DTH) was 
described in tuberculosis and it was suggested that
cellular types of immune responses were involved in
both (28). CMI was defined as a beneficial host
response and DTH as the immunological reaction
that caused caseous necrosis (23). Although
tuberculin-positive hosts with good CMI and
tuberculin-positive hosts with poor CMl could arrest
bacillary growth, the host with good CMI might
recover whereas the host with poor CMI might suffer
excessive tissue destruction (23). All patients in Our
study had strong tuberculin reaction (> 10 mm) and
the observation of two types of cell profile may.
therefore, suggest the possibility that one group may
have tuberculin- reactive good CMI and the other
tuberculin-reactive poor CMI. It had also been
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suggested that two mechanisms of cell mediated
responses referred  to as the Listeria-type and the
Koch- type could occur in infections with
mycobacteria and the Listeria-type is thought to
provide protective immunity (29,30). It had also been
described previously that healing could occur in a
proportion of tuberculous patients without treatment
(31, 32) which might be due to the development of
good CMI in some of these patients. The finding of
generalised recruitment of macrophages to the lung
in one group may, therefore, suggest the inability of
the host to localise the immune response as
r eserved in lymphocyte predominant group. We
have recently reported that lymphocytic alveolitis in
tuberculosis patients is associated with increased
bactericidal activity against Staphylococcus aureus,
whereas no lymphocytic alveolitis is associated with
reduced activity (33). Ethical considerations will not
permit the follow up without treatment to know the
fate of these patients. However; Immunological
studies of the cytokines (34,35) released from lung
immune and inflammatory cells to assess the
immunologic competence of the host may aid in
understanding the pathogenesis of tissue
destruction and healing in pulmonary tuberculosis.
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